Details
DIFLAZON INDICATIONS
Cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. skin and lungs).
Treatment of carriers and AIDS patients, transplant patients, and patients receiving immunosuppressive therapy.
To prevent relapse of cryptococcosis in patients with AIDS.
Generalized candidiasis including candidemia, disseminovanny candidiasis and other forms of invasive Candida infections (abdominal lesion, endocarditis, respiratory and urinary tract).
Treatment of patients with malignancies who are in the ICU and receiving cytotoxic and immunosuppressive therapy.
Candidiasis of the mucous membranes - the defeat of oropharyngeal, esophageal, non-invasive bronchopulmonary infection, candiduria, mucocutaneous and chronic atrophic candidiasis (candidiasis, caused by denture).
As a prophylactic agent of relapse of oropharyngeal candidiasis in patients with AIDS.
Prevention of fungal infections in patients with malignancies who are prone to infection due to radiotherapy or chemotherapy, including bone marrow transplantation.
Dermatomycoses - athlete's foot, tinea corporis, tinea groin, pityriasis versicolor, ringworm nail (onychomycosis) and dermal candida infections.
Deep endemic mycoses in patients with an intact immune system, coccidioidomycosis, parakoktsidoidomikoz, sporotrichosis and histoplasmosis.
APPLICATION
The daily dose of fluconazole depends on the nature and severity of the infection fungalnoy.
Treatment of infections which require repeated administration of drugs should last until clinical and laboratory effect (attenuation active fungal infection). Insufficient duration of treatment can lead to recovery of the active infection. Patients with AIDS and cryptococcal meningitis or recurrent oropharyngeal candidiasis usually require maintenance therapy to prevent relapse.
Therapy can be started before the results of the culture or other laboratory investigations and in their preparation and antimicrobial agents are added.